- Home
- RLAY vs TSSI Comparison
RLAY vs TSSI Comparison
Compare RLAY & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- TSSI
- Stock Information
- Founded
- RLAY 2015
- TSSI 2004
- Country
- RLAY United States
- TSSI United States
- Employees
- RLAY N/A
- TSSI N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- TSSI Professional Services
- Sector
- RLAY Health Care
- TSSI Consumer Discretionary
- Exchange
- RLAY Nasdaq
- TSSI Nasdaq
- Market Cap
- RLAY 610.3M
- TSSI 640.8M
- IPO Year
- RLAY 2020
- TSSI N/A
- Fundamental
- Price
- RLAY $3.74
- TSSI $28.95
- Analyst Decision
- RLAY Strong Buy
- TSSI
- Analyst Count
- RLAY 11
- TSSI 0
- Target Price
- RLAY $18.40
- TSSI N/A
- AVG Volume (30 Days)
- RLAY 2.3M
- TSSI 2.7M
- Earning Date
- RLAY 08-05-2025
- TSSI 08-21-2025
- Dividend Yield
- RLAY N/A
- TSSI N/A
- EPS Growth
- RLAY N/A
- TSSI 770.13
- EPS
- RLAY N/A
- TSSI 0.35
- Revenue
- RLAY $7,679,000.00
- TSSI $231,211,000.00
- Revenue This Year
- RLAY $17.59
- TSSI N/A
- Revenue Next Year
- RLAY N/A
- TSSI N/A
- P/E Ratio
- RLAY N/A
- TSSI $76.78
- Revenue Growth
- RLAY N/A
- TSSI 262.87
- 52 Week Low
- RLAY $1.78
- TSSI $2.12
- 52 Week High
- RLAY $10.72
- TSSI $31.94
- Technical
- Relative Strength Index (RSI)
- RLAY 58.29
- TSSI N/A
- Support Level
- RLAY $3.47
- TSSI N/A
- Resistance Level
- RLAY $3.97
- TSSI N/A
- Average True Range (ATR)
- RLAY 0.20
- TSSI 0.00
- MACD
- RLAY -0.00
- TSSI 0.00
- Stochastic Oscillator
- RLAY 54.00
- TSSI 0.00
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About TSSI TSS Inc. Common Stock
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.